Effects of 1-[bis(4-fluorophenyl)methyl]-4-(2,3,4-trimethoxybenzyl) piperazine dihydrochloride, a new synthesized Ca2+ blocker KB-2796, on free fatty acid liberation in ischemic brain in rats.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D002545:Brain Ischemia / Q000188:drug therapy / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000494:pharmacology* / Q000627:therapeutic use; D005230:Fatty Acids, Nonesterified / Q000378:metabolism*; D008297:Male; D010879:Piperazines / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains
D002121:Calcium Channel Blockers; D005230:Fatty Acids, Nonesterified; D010879:Piperazines; C052424:lomerizine